The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APPLIED DIGITAL CORP | COM NEW | 038169207 | 58,950,622 | 7,716,050 | SH | SOLE | 7,716,050 | 0 | 0 | ||
| ARM HOLDINGS PLC | SPONSORED ADS | 042068205 | 135,850,077 | 1,101,249 | SH | SOLE | 1,101,249 | 0 | 0 | ||
| NEBIUS GROUP N.V. | SHS CLASS A | N97284108 | 32,976,185 | 1,190,476 | SH | SOLE | 1,190,476 | 0 | 0 | ||
| RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | 52,095,014 | 7,706,363 | SH | SOLE | 7,706,363 | 0 | 0 | ||
| WERIDE INC | SPONSORED ADS | 950915108 | 24,652,823 | 1,738,563 | SH | DFND | 1,738,563 | 0 | 0 | ||
